Efficacy and safety of galcanezumab as chronic cluster headache preventive treatment under real world conditions: Observational prospective study
Authors:
Posted in Papers / Human Studies|Original Research / March 16-31, 2024
Cephalalgia. 2024 Mar;44(3):3331024231226181. doi: 10.1177/03331024231226181.
PMID: 38501892 | DOI: 10.1177/03331024231226181
Share this article
Sign Up For An MSC Newsletter
Register to Watch the MSC Emerging Science Contest!
The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.